Pharmacological in vivo test to evaluate the bioavailability of some St John's Wort innovative oral preparations

In this study, the optimisation of biopharmaceutical properties of a dried commercial extract of St John's Wort were evaluated employing the in vivo forced swimming test (FST). Three new dosage forms containing β‐cyclodextrin and surfactants (SDS, ASC8) were compared in the FST with the commercial extract. The commercial extract showed antidepressant activity in mice after 60 min at a dosage of 100 mg/kg. The same antidepressant activity appeared in 30 min with a micellar solution of SDS containing the same quantity of extract (100 mg/kg), while with micelles of ASC8 the effect appeared at 15 min and with a dosage of 30 mg/kg. In the case of β‐cyclodextrin the best results were obtained at 30 min, administering 60 mg/kg of the extract. Finally, the influence of the formulations on the water solubility of the constituents of the extract is reported. The tensides dramatically enhanced solubility, in particular that of the more lipophilic compounds, in the case of β‐cyclodextrin this effect was very pronounced for flavonoids and biapigenin, lower for hypericins and practically insignificant for hyperforins. Copyright © 2008 John Wiley & Sons, Ltd.

[1]  F. Hirayama,et al.  Pharmaceutical Applications of Cyclodextrins and Their Derivatives , 2006 .

[2]  A. Hedges Industrial Applications of Cyclodextrins. , 1998, Chemical reviews.

[3]  G. Harrer,et al.  Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study. , 1994, Journal of geriatric psychiatry and neurology.

[4]  A. Meli,et al.  Is the forced swimming test a suitable model for revealing antidepressant activity? , 2004, Psychopharmacology.

[5]  L. Costa,et al.  A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen , 1985, Neuropharmacology.

[6]  D. Savio,et al.  Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[7]  B. Steinhoff,et al.  Herbal Medicinal Products , 2003 .

[8]  F. Hirayama,et al.  Cyclodextrin-based controlled drug release system. , 1999, Advanced drug delivery reviews.

[9]  R. Porsolt,et al.  Behavioral despair in mice: a primary screening test for antidepressants. , 1977, Archives internationales de pharmacodynamie et de therapie.

[10]  S. Chatterjee,et al.  Oral Bioavailability of Hyperforin from Hypericum Extracts in Rats and Human Volunteers , 1998, Pharmacopsychiatry.

[11]  V. Stella,et al.  Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. , 1996, Journal of pharmaceutical sciences.

[12]  S. Bhattacharya,et al.  Hyperforin as a possible antidepressant component of hypericum extracts. , 1998, Life sciences.

[13]  Manfred Schubert-Zsilavecz,et al.  Hypericum Perforatum: A ‘Modern’ Herbal Antidepressant , 2006, Clinical pharmacokinetics.

[14]  M. Nöldner,et al.  Rutin is Essential for the Antidepressant Activity of Hypericum perforatum Extracts in the Forced Swimming Test , 2002, Planta medica.

[15]  H. Schulz,et al.  Investigation of the Bioavailability of Hypericin, Pseudohypericin, Hyperforin and the Flavonoids Quercetin and Isorhamnetin Following Single and Multiple Oral Dosing of a Hypericum Extract Containing Tablet , 2005, Arzneimittelforschung.

[16]  A. Kubin,et al.  Hypericin--the facts about a controversial agent. , 2005, Current pharmaceutical design.

[17]  F. Panzeri,et al.  Identification by high-performance liquid chromatography–diode array detection–mass spectrometry and quantification by high-performance liquid chromatography–UV absorbance detection of active constituents of Hypericum perforatum , 1998 .

[18]  M. Detke,et al.  Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth , 1995, Behavioural Brain Research.

[19]  M. Nöldner,et al.  Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility , 1998, Pharmacopsychiatry.

[20]  A. Nahrstedt,et al.  Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. , 1998, Planta medica.

[21]  A. Bilia,et al.  Variability in the Content of the Constituents of Hypericum perforatum L. and Some Commercial Extracts , 2001, Drug development and industrial pharmacy.

[22]  Veronika Butterweck,et al.  Mechanism of Action of St John’s Wort in Depression , 2003, CNS drugs.